Prognostic value of c-Met expression in oral squamous cell carcinoma

Experimental and Therapeutic Medicine

Volumn 1, Issue 1, 2010, Pages 69-72

  Freudlsperger, Christian ^a   Alexander, Dorothea ^a   Reinert, Siegmar ^a   Hoffmann, Juergen ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Hepatocyte growth factor; Lymph node metastasis c Met; Oral squamous cell carcinoma; Prognosis; Survival

Indexed keywords

SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 77955723630     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000012     Document Type: Article

References (24)

1. Lothaire P, De Azambuja E, Dequanter D, et al: Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 28: 256-269, 2006.
2. De Herdt MJ and Baatenburg De Jong RJ: HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma. Front Biosci 13: 2516-2526, 2008.
3. Lo Muzio L, Farina A, Rubini C, et al: Effect of c-Met expression on survival in head and neck squamous cell carcinoma. Tumour Biol 27: 115-121, 2006.
4. Bottaro DP, Rubin JS, Faletto DL, et al: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
5. Birchmeier C and Gherardi E: Developmental roles of HGF/SF and its receptor, the c-met tyrosine kinase. Trends Cell Biol 8: 404-410, 1998.
6. Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
7. Zarnegar R and Michalopoulos GK: The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1995.
8. Chen YS, Wang JT, Chang YF, et al: Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 33: 209-217, 2004.
9. To C and Tsao M: The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). Oncol Rep 5: 1013-1024, 1998.
10. Uchida D, Kawamata H, Omotehara F, et al: Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 93: 489-496, 2001.
11. Matsumoto K, Nakamura T and Kramer RH: Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125(FAK)) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269: 31807-31813, 1994.
12. Patel SG and Shah JP: TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55: 242-258, 2005.
13. Kunkel M, Reichert T, Benz P, et al: Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97: 1015-1024, 2003.
14. Kim CH, Moon SK, Bae JH, et al: Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol 126: 88-94, 2006.
15. Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O and Shin T: Expression of c-Met in laryngeal carcinoma. Virchows Arch 432: 331-335, 1998.
16. Galeazzi E, Olivero M, Gervasio FC, et al: Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 254: S138-S143, 1997.
17. Lo Muzio L, Leonardi R, Mignogna MD, et al: Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma. Anticancer Res 24: 1063-1069, 2004.
18. Marshall DD and Kornberg LJ: Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma. Laryngoscope 108: 1413-1417, 1998.
19. Nakajima M, Sawada H, Yamada Y, et al: The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85: 1894-1902, 1999.
20. Hanzawa M, Shindoh M, Higashino F, et al: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21: 1079-1085, 2000.
21. Murai M, Shen X, Huang L, et al: Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. Int J Oncol 25: 831-840, 2004.
22. Han SU, Lee JH, Kim WH, Cho YK and Kim MW: Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg 23: 1176-1180, 1999.
23. Moghul A, Lin L, Beedle A, et al: Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 9: 2045-2052, 1994.
24. Boccaccio C, Gaudino G, Gambarotta G, Galimi F and ComoglioPP: Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem 269: 12846-12851, 1994.